Literature DB >> 28589484

Longitudinal Volume Quantification of Deep Medullary Veins in Patients with Cerebral Venous Sinus Thrombosis : Venous Volume Assessment in Cerebral Venous Sinus Thrombosis Using SWI.

A K Dempfle1, A Harloff2, F Schuchardt3, J Bäuerle4, S Yang1, H Urbach1, K Egger1,5.   

Abstract

PURPOSE: Susceptibility-weighted imaging (SWI) visualizes small cerebral veins with high sensitivity and could, thus, enable quantification of hemodynamics of deep medullary veins. We aimed to evaluate volume changes of deep medullary veins in patients with acute cerebral venous sinus thrombosis (CVST) over time in comparison to healthy controls.
METHODS: All magnetic resonance imaging (MRI) experiments were executed at 3 T using a 32-channel head coil. Based on SWI and semiautomatic postprocessing (statistical parametric mapping [SPM8] and ANTs), the volume of deep medullary veins was quantified in 14 patients with acute CVST at baseline and the 6‑month follow-up, as well as in 13 healthy controls undergoing repeated MRI examination with an interscan interval of at least 1 month.
RESULTS: Deep medullary venous volume change over time was significantly different between healthy controls and patient groups (p < 0.001). Patients with superior sagittal sinus thrombosis (SSST) showed a significant decline from baseline to follow-up measurements (9.8 ± 4.9 ml versus 7.5 ± 4.2 ml; p = 0.02), whereas in patients with transverse sinus thrombosis (TST) and healthy controls no significant volume changes were observable.
CONCLUSIONS: Venous volume quantification was feasible and reproducible both in healthy volunteers and in patients. The decrease of venous volume in patients over time represents improvement of venous drainage, reduction of congestion, and normalization of microcirculation due to treatment. Thus, quantification of venous microcirculation could be valuable for estimation of prognosis and guidance of CVST therapy in the future.

Entities:  

Keywords:  Cerebral veins; Cerebral venous sinus thrombosis; Deep medullary veins; MRI; SWI; Stroke; Susceptibility-weighted imaging

Mesh:

Substances:

Year:  2017        PMID: 28589484     DOI: 10.1007/s00062-017-0602-z

Source DB:  PubMed          Journal:  Clin Neuroradiol        ISSN: 1869-1439            Impact factor:   3.649


  32 in total

1.  Transcranial color-coded duplex sonography of intracranial veins and sinuses in adults. Reference data from 130 volunteers.

Authors:  E Stolz; M Kaps; A Kern; S S Babacan; W Dorndorf
Journal:  Stroke       Date:  1999-05       Impact factor: 7.914

Review 2.  Diagnosis of cerebral venous thrombosis with echo-planar T2*-weighted magnetic resonance imaging.

Authors:  Magdy Selim; John Fink; Italo Linfante; Sandeep Kumar; Gottfried Schlaug; Louis R Caplan
Journal:  Arch Neurol       Date:  2002-06

Review 3.  Cerebral venous thrombosis: an update.

Authors:  Marie-Germaine Bousser; José M Ferro
Journal:  Lancet Neurol       Date:  2007-02       Impact factor: 44.182

4.  Avoiding asymmetry-induced bias in longitudinal image processing.

Authors:  Martin Reuter; Bruce Fischl
Journal:  Neuroimage       Date:  2011-03-03       Impact factor: 6.556

5.  N4ITK: improved N3 bias correction.

Authors:  Nicholas J Tustison; Brian B Avants; Philip A Cook; Yuanjie Zheng; Alexander Egan; Paul A Yushkevich; James C Gee
Journal:  IEEE Trans Med Imaging       Date:  2010-04-08       Impact factor: 10.048

6.  EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients.

Authors:  K Einhäupl; J Stam; M-G Bousser; S F T M De Bruijn; J M Ferro; I Martinelli; F Masuhr
Journal:  Eur J Neurol       Date:  2010-10       Impact factor: 6.089

7.  Quantification of the human cerebrovasculature: a 7Tesla and 320-row CT in vivo study.

Authors:  Wieslaw Lucjan Nowinski; Fiftarina Puspitasari; Ihar Volkau; William W Orrison; Michael V Knopp
Journal:  J Comput Assist Tomogr       Date:  2013 Jan-Feb       Impact factor: 1.826

8.  Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT).

Authors:  José M Ferro; Patrícia Canhão; Jan Stam; Marie-Germaine Bousser; Fernando Barinagarrementeria
Journal:  Stroke       Date:  2004-02-19       Impact factor: 7.914

Review 9.  Susceptibility-weighted MR imaging: a review of clinical applications in children.

Authors:  K A Tong; S Ashwal; A Obenaus; J P Nickerson; D Kido; E M Haacke
Journal:  AJNR Am J Neuroradiol       Date:  2007-10-09       Impact factor: 3.825

10.  MRI of clot in cerebral venous thrombosis: high diagnostic value of susceptibility-weighted images.

Authors:  Ahmed Idbaih; Monique Boukobza; Isabelle Crassard; Raphaël Porcher; Marie-Germaine Bousser; Hugues Chabriat
Journal:  Stroke       Date:  2006-02-16       Impact factor: 7.914

View more
  4 in total

1.  Recanalization, reperfusion, and recirculation in stroke.

Authors:  John H Zhang; Andre Obenaus; David S Liebeskind; Jiping Tang; Richard Hartman; William J Pearce
Journal:  J Cereb Blood Flow Metab       Date:  2017-09-19       Impact factor: 6.200

2.  High-resolution susceptibility-weighted imaging of clots in cerebral venous thrombosis.

Authors:  Faiza Boukerche; Sivasubramanian Balakrishnan; Paul Kalapos; Krishnamoorthy Thamburaj
Journal:  Neuroradiology       Date:  2022-07-12       Impact factor: 2.995

Review 3.  Deep medullary vein engorgement and superficial medullary vein engorgement: two patterns of perinatal venous stroke.

Authors:  Hedieh Khalatbari; Jason N Wright; Gisele E Ishak; Francisco A Perez; Catherine M Amlie-Lefond; Dennis W W Shaw
Journal:  Pediatr Radiol       Date:  2020-10-22

4.  Quantification of cerebral veins in patients with acute migraine with aura: A fully automated quantification algorithm using susceptibility-weighted imaging.

Authors:  Philipe Sebastian Breiding; Frauke Kellner-Weldon; Lorenz Grunder; Adrian Scutelnic; Urs Fischer; Thomas Raphael Meinel; Nedelina Slavova; Jan Gralla; Marwan El-Koussy; Niklaus Denier
Journal:  PLoS One       Date:  2020-06-03       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.